TickerFacts.

Solventum Corp (SOLV): Operating Income

Annual figures by period end, from SEC filings.

$2.18B
Year ended 2025-12-31
$2.08B
Trailing 12 months to 2026-06-30
+8.8%
3-year compound annual growth
2022-12-31: $1.69B2023-12-31: $1.69B2024-12-31: $1.04B2025-12-31: $2.18B$2.18B
2022-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31$2.18B+110.5%2026-02-27, From 2025-01-01
2024-12-31$1.04B-38.8%2026-02-27, From 2024-01-01
2023-12-31$1.69B-0.1%2026-02-27, From 2023-01-01
2022-12-31$1.69Bn/a2025-02-28, From 2022-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Solventum Corp (SOLV)2025-12-31$2.18B+110.5%
Baxter International Inc (BAX)2025-12-31-$308.00Mn/m
ResMed Inc (RMD)2026-06-30$1.89B+11.9%
Dexcom Inc (DXCM)2025-12-31$911.80M+52.0%
Boston Scientific Corp (BSX)2025-12-31$3.61B+38.8%
Becton Dickinson & Co (BDX)2025-09-30$2.58B+7.6%
MiniMed Group, Inc. (MMED)2026-04-24-$190.00Mn/m
West Pharmaceutical Services Inc (WST)2025-12-31$584.90M+2.6%
Globus Medical Inc (GMED)2025-12-31$479.82M+189.1%

Compare SOLV, BAX, RMD, DXCM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗